SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-002241
Filing Date
2023-01-23
Accepted
2023-01-23 18:16:12
Documents
1
Period of Report
2023-01-19

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 11231
  Complete submission text file 0001493152-23-002241.txt   12813
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Ayala Pharmaceuticals, Inc. (Issuer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GERON CORPORATION 230 CONSTITUTION DRIVE MENLO PARK CA 94025
Business Address
Spiegel Robert J. (Reporting) CIK: 0001492256 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36138 | Film No.: 23545477